DAREON ™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With Topotecan

Condition:   Small Cell Lung Carcinoma (SCLC) Interventions:   Drug: BI 764532;   Drug: Topotecan Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials